| Gut microbiota: next frontier in understanding human health and development of biotherapeutics S Prakash, L Rodes, M Coussa-Charley, C Tomaro-Duchesneau Biologics: targets & therapy 5, 71-86, 2011 | 369 | 2011 |
| Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy S Prakash, M Malhotra, W Shao, C Tomaro-Duchesneau, S Abbasi Advanced drug delivery reviews 63 (14-15), 1340-1351, 2011 | 309 | 2011 |
| Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases M Malhotra, C Tomaro-Duchesneau, S Prakash Biomaterials 34, 1270-1280, 2012 | 215 | 2012 |
| Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications ML Jones*, C Tomaro-Duchesneau*, CJ Martoni, S Prakash Expert Opinion on Biological Therapy 13 (5), 631-642, 2013 | 210 | 2013 |
| Effect of Probiotics Lactobacillus and Bifidobacterium on Gut-Derived Lipopolysaccharides and Inflammatory Cytokines: An In Vitro Study Using a Human Colonic Microbiota Model L Rodes, A Khan, A Paul, M Coussa-Charley, D Marinescu, ... Journal of Microbiology and Biotechnology, 2013 | 202 | 2013 |
| Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation C Tomaro-Duchesneau, ML Jones, D Shah, P Jain, S Saha, S Prakash BioMed Research International, 2014 | 175 | 2014 |
| Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of actions and current prospectives I Kahouli, C Tomaro-Duchesneau, S Prakash Journal of Medical Microbiology 62 (Pt 8), 1107-1123, 2013 | 159 | 2013 |
| The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells S Prakash, C Tomaro-Duchesneau, S Saha, A Cantor BioMed Research International 2011, 2011 | 159 | 2011 |
| A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis M Malhotra, C Lane, C Tomaro-Duchesneau, S Saha, S Prakash International journal of nanomedicine, 485-494, 2011 | 122 | 2011 |
| Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA M Malhotra, C Tomaro-Duchesneau, S Saha, I Kahouli, S Prakash International Journal of Nanomedicine 8, 2041-2052, 2013 | 114 | 2013 |
| Microencapsulation for the therapeutic delivery of drugs, live mammalian and bacterial cells and other biopharmaceutics: current status and future directions C Tomaro-Duchesneau, S Saha, M Malhotra, I Kahouli, S Prakash Journal of Pharmaceutics, 2013 | 113 | 2013 |
| Probiotics as oral health biotherapeutics S Saha, C Tomaro-Duchesneau, M Tabrizian, S Prakash Expert opinion on biological therapy 12 (9), 1207-1220, 2012 | 93 | 2012 |
| Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats C Tomaro-Duchesneau, S Saha, M Malhotra, ML Jones, A Labbé, ... Applied Microbiology and Biotechnology 98 (1), 115-126, 2014 | 91 | 2014 |
| Human intestinal enteroids with inducible neurogenin-3 expression as a novel model of gut hormone secretion AL Chang-Graham, HA Danhof, MA Engevik, C Tomaro-Duchesneau, ... Cellular and Molecular Gastroenterology and Hepatology 8 (2), 209-229, 2019 | 71 | 2019 |
| Probiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 APA Microcapsules for Oral Delivery: Preparation and in Vitro Characterization C Tomaro-Duchesneau, S Saha, M Malhotra, M Coussa-Charley, ... Pharmaceuticals 5 (2), 236-248, 2012 | 70 | 2012 |
| The gut microbiome, probiotics, bile acids axis, and human health ML Jones*, C Tomaro-Duchesneau*, S Prakash Trends in Microbiology, 2014 | 69 | 2014 |
| Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F1B Golden Syrian Hamsters J Bhathena, C Martoni, A Kulamarva, C Tomaro-Duchesneau, M Malhotra, ... PLoS ONE 8 (3), e58394, 2013 | 66 | 2013 |
| Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats L Rodes, S Saha, C Tomaro-Duchesneau, S Prakash Biomed Research International, 2014 | 51 | 2014 |
| Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics S Saha, C Tomaro-Duchesneau, L Rodes, M Malhotra, M Tabrizian, ... Beneficial microbes 5 (4), 447-460, 2014 | 47 | 2014 |
| Lactobacillus fermentum NCIMB 5221 has a greater ferulic acid production compared to other ferulic acid esterase producing Lactobacilli C Tomaro-Duchesneau, S Saha, M Malhotra, M Coussa-Charley, ... Int. J. Probiotics Prebiotics 7 (1), 23-32, 2012 | 47 | 2012 |
Dr. Satya PrakashProfessor of Biomedical Engineering, Faculty of Medicine and Health Sciences, McGill UniversityVerified email at mcgill.ca
